FDA Approves Kresladi, First Gene Therapy for Severe LAD-I

The FDA has approved Kresladi (marnetegragene autotemcel), the first gene therapy for severe Leukocyte Adhesion Deficiency Type I (LAD-I) in pediatric patients. This accelerated approval offers a new treatment option for a rare inherited immune deficiency, targeting the underlying genetic cause of the disease.

Bobby Hampton v. Governor Jeff Landry - Writ Denied

The Louisiana Court of Appeal, First Circuit, denied a writ in Bobby Hampton v. Governor Jeff Landry, docket 2025 CW 1267. Two judges dissented, stating they would have granted the writ and reversed a portion of the lower court's judgment regarding an exception of no cause of action.

James H. Cureton v. James B. "Blake" Cureton - Rehearing Denied

The Louisiana Court of Appeal, Third Circuit, denied the application for rehearing filed by James B. "Blake" Cureton in the case of James H. Cureton v. James B. "Blake" Cureton. The judgment was rendered and mailed to parties on March 25, 2026.

Succession of Vernon James Goudeau - Affirmation of Lower Court Ruling

The Louisiana Court of Appeal, Third Circuit, affirmed a lower court's ruling in the Succession of Vernon James Goudeau. The appellate court found that the plaintiff failed to prove she was a forced heir and therefore not entitled to a portion of the estate.

Deutsche Bank v. Landry - Rehearing Denied

The Louisiana Court of Appeal, Third Circuit, denied the application for rehearing filed by Derinda R. Landry in the case of Deutsche Bank National Trust Company v. Derinda R. Landry. The judgment on rehearing was rendered and mailed on March 25, 2026.

Stanley v. Lafayette Police Department - Affirmation of Judgment

The Louisiana Court of Appeal affirmed a lower court's judgment in favor of the Lafayette Police Department and Scott Morgan. The case involved David Stanley, a former police union president, who appealed disciplinary actions related to his social media posts. The court found the exception of res judicata to be applicable.

State of Louisiana v. Sammy Cheatham - Sentencing Affirmation

The Louisiana Court of Appeal affirmed the sentences of Sammy Cheatham, who was convicted of attempted second-degree murder. The court noted a patent error in the sentencing, but the sentences were affirmed as imposed. Cheatham was sentenced to thirty years on each of seven counts, to run concurrently.

Colorado PUC Announces April Public Comment and Engagement Opportunities

The Colorado Public Utilities Commission (PUC) has announced public comment and engagement opportunities for April 2026. Key events include public comment hearings for Atmos Energy's proposed gas rate increase (Proceeding No. 25AL-0499G), which seeks an approximate $17.56 million increase in annual base rate revenues.

USPTO Patent Application for Compounds Targeting Pax3/Foxo1 Fusion Protein

The USPTO has published patent application US20260083724A1, filed by Georgetown University, for novel compounds designed to target the PAX3::FOXO1 fusion protein. These compounds aim to reduce protein levels and treat fusion-positive rhabdomyosarcoma.

Patent Application: Sigmari Ligand for Pancreatic Cancer Treatment

The USPTO has published a patent application (US20260083725A1) for a Sigmari Ligand for the treatment of pancreatic cancer. The application details a method involving a Sig-1R ligand to inhibit tumor growth and metastasis, filed on August 9, 2023.